By NewsDesk @ bactiman63
In a follow-up to a post from earlier this month, the Swedish Public Health Agency has decided to continue to recommend Pfizer / Biontech’s COVID-19 vaccine, Comirnaty, to anyone born in 1991 or later.
On 6 October 2021, the Swedish Public Health Agency decided to recommend a break for vaccinations with Moderna’s vaccine Spikevax among people born in 1991 and later. The decision was valid until 1 December.
The Swedish Public Health Agency has now decided that the recommendation will continue to apply, for example even after 1 December.
People born in 1991 and later are recommended to receive Comirnaty as protection against covid-19. This applies to both those who have not previously been vaccinated against covid-19, and those who have received Spikevax as the first dose.
Now everyone under the age of 30 who is waiting for their second dose can get it, says Andes Tegnell, head of department and state epidemiologist at the Swedish Public Health Agency.
The background to the decision to pause the use of Spikevax for people born in 1991 and later is signals of an increased risk of myocarditis (myocarditis) and pericarditis (pericarditis).